- Simplify Wall Street
- Posts
- Bulls Win π | Education π | End of Week Update!
Bulls Win π | Education π | End of Week Update!
Analysis + Setups

Happy Thursday βοΈ
Since this is a short week, I have provided some educational posts below that may be interesting and helpful.
Hereβs a friendly recommendation if you are into Real Estate Investing
(Note: this is a one-click subscribe link)
π Want to build your wealth?
π Grow your portfolio?
πΈ Become an even better investor?
Then you need the Best Ever CRE Newsletter.
Each week, you'll receive expert tips, the latest news, and free tools from the commercial real estate industry to help you create the future of your dreams...for free.
Join over 19,000 readers who are learning and investing with confidence. Subscribe today!

Now, back to SWS
Table of Content
Intraday Trading Insights for 03-28-24
Education
π Volume Analysis Strategy Coming Sunday for Premium members.
Weβve unlocked a couple of premium notes for a day. Check it out! π
ποΈ Sunday Read Premium Levels 03.24.24 (unlocked)
ποΈ Intraday Insights 03.21.24 (unlocked)
Having a good morning? |
Webinar
If you missed the Zoom call about Risk Management, Ratio Trading, Gradually Building a Small Account, and Overcoming being a later starter, You can watch the lesson HERE!
Next Webinar Topic |
Context
So far our βContinuation until Thursdayβ has held.
Many of our big chip stocks have declined such as NVDA and SMCI, which were both great wins as we traded them up to their resistances.
$SMCI - Bought at $510 and sold at $1,390. Total +$880 in profit per contract.


Now the rotation continues into _______ π
Weβre just getting started.
Simplifying your investing and trading is easier with the right insights at hand.
Already a paying subscriber? Sign In.
Simplifying Wall Street 1 Tool At A Time:
- β’ β Follow fully curated watchlists with step-by-step action plans.
- β’ π Access weekly deep-dive research on companies hitting our radar.
- β’ π Get real-time buy & sell alerts β straight to your email.
- β’ π Curious about our beta screening and analyzation tools?
Reply